CLINICAL EVIDENCE Treatment of Venous Leg Ulcers (VLUs)
|
|
- Silvia Griffith
- 6 years ago
- Views:
Transcription
1 CLINICAL EVIDENCE Treatment of Venous Leg Ulcers (VLUs) Endoform can help to improve healing and lower the cost of VLU management Endoform can be used from day one in difficult-to-manage VLU s. 1, 2, 3, 4 Endoform does not need to be removed and requires fewer dressing changes than other products; which may lead to greater patient satisfaction and compliance. 5 Endoform reduces the cost of VLU treatment because application can be carried out by a range of wound care practitioners (no suturing required) and subsequent applications can be carried out by the patient at home. 5 A case series using Endoform was shown to result in 95.7% closure of VLUs in 12 weeks with an average closure time of 7.3 weeks (n=23 wounds, ranging in size from cm2, in 14 patients). 5 Early reduction in wound area (20-40% in the first 2-4 weeks of treatment) is a good predictor of healing. 6 In a clinical study, 4 weeks of Endoform treatment resulted in complete closure in 40% of cases (n=28). 1 Week 0: Week 11: Week 7: Endoform treatment of ankle VLU. 5 Endoform can be used at all phases of wound management Stabilize Correct Build Organize Hemostasis Inflammation Proliferation Remodelling Wound Closure MKT
2 CLINICAL EVIDENCE Treatment of Venous Leg Ulcers (VLUs) Natural Dermal Template Antimicrobial Dermal Template References 1. Lullove, E. (2016). Use of Ovine Collagen Extracellular Matrix and Gentian Violet and Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds. Symposium on Advanced Wound Care - Fall, Las Vega, NA. 2. Liden BA, (2011). Case Study 1: Mixed Vascular Disease, from "Early Clinical Findings From The Use Of Endoform Dermal Template (Ovine Forestomach Matrix) To Treat Recalcitrant Wounds"; Presented at Symposium on Advanced Wound Care, April 14-17, 2011 Dallas, TX 3. Liden BA, (2011). Case Study 3: Mixed Vascular Etiology, from "Early Clinical Findings From The Use Of Endoform Dermal Template (Ovine Forestomach Matrix) To Treat Recalcitrant Wounds"; Presented at Symposium on Advanced Wound Care, April 14-17, 2011 Dallas, TX. 4. Curran, M. (2013). Case Study 9: Venous Ulcer, Aroa Biosurgery. 5. Bohn, G. A. and K. Gass (2014). "Leg ulcer treatment outcomes with new ovine collagen extracellular matrix dressing: a retrospective case series." Adv Skin Wound Care 27(10): Bohn, G. A., G. S. Schultz, B. A. Liden, M. N. Desvigne, E. J. Lullove, I. Zilberman, M. B. Regan, M. Ostler, K. Edwards, G. M. Arvanitis and J. F. Hartman (2017). "Proactive and Early Aggressive Wound Management: A Shift in Strategy Developed by a Consensus Panel Examining the Current Science, Prevention, and Management of Acute and Chronic Wounds." Wounds 29(11): S37-S42. RX Only. Prior to use, be sure to read the entire Instructions for Use package insert supplied with the product. For product questions, sampling needs, or detailed clinical questions concerning our products in the US, please call HCPCS are for reference only and subject to change. Endoform is a registered trademark of Aroa Biosurgery Limited. Manufactured for: AROA BIOSURGERY INC 340 Progress Drive, Manchester, CT Endoform Dermal Template is marketed in the USA by Appulse 2018 Aroa Biosurgery Limited MKT May 2018
3 Use of Ovine Collagen Extracellular Matrix and Gentian Violet and Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds Eric J. Lullove, DPM, CWS, FACCWS West Boca Center for Wound Healing, Boca Raton, FL Purpose: To analyze our clinical outcomes with use of ovine collagen extracellular matrix (CECM)* and gentian violet/methylene blue (GV/ MB) polyurethane (PU) antibacterial foam dressings** in treating chronic lower extremity wounds. Introduction: Chronic lower extremity wounds are increasingly more prevalent and complex to treat, and are a significant cause of morbidity and drain on healthcare resources worldwide. Patient comorbid conditions such diabetes, peripheral vascular disease and obesity can delay wound healing, and must be clinically addressed to correct causes of tissue damage. In addition to underlying medical conditions, chronic wounds are characterized by a complex etiology that can include abnormal cell-extracellular matrix (ECM) interactions, elevated bioburden levels and bacterial biofilm, imbalances of matrix-metalloproteinases (MMP), and an unresolved inflammatory response all of which can damage the wound ECM. 1,2 Dressings that provide broad spectrum MMP reduction along with inherent aspects of an ECM may contribute to improved wound healing outcomes and shorter treatment times. 3 Preliminary reports of a CECM dressing have demonstrated benefits in chronic wound healing. 4,5 Methodology: Retrospective chart analysis was performed on observational data of consecutive patients with chronic lower extremity ulcers who were managed with CECM as a primary dressing and MB/GV PU antibacterial foam dressing to manage bioburden as a secondary dressing in an outpatient setting. All patients were treated twice weekly in the clinic for the first four weeks. During the first visit, wounds were cleansed with saline or dermal cleanser, sharp debrided as needed, and a CECM dressing covered with a MB/GV PU antibacterial foam was placed. At the mid-week appointment, wounds were again cleansed and examined, but not sharp debrided. An additional CECM dressing was placed if the previous CECM dressing was fully integrated into the wound and the MB/GV PU antibacterial foam was replaced. After the initial four week period, patients received once weekly treatment consisting of cleansing, sharp debridement as needed, and a CECM dressing covered with a GV/MB PU antibacterial foam until wound was healed. Results: Patient demographics n % Patients (n) 53 Male % Female % Mean age (years) 75.9 Mean Body Mass Index (BMI) 28.3 Wounds treated (n) 53 Mean wound area at presentation (cm2) 5.8 Fifty-three patients with 53 wounds were treated. Types of wounds treated were diabetic foot ulcers (n=22), venous leg ulcers (n=28), and heel pressure ulcers (n=3). Average BMI for study population was 28.3 using a standard BMI formula with a BMI between 25 and 30 being overweight; average patient age was 75.9 years. Mean percent wound size reduction at 4 weeks was 38.5%; mean wound size reduction at 8 and 12 weeks was 73.3% and 91.3%, respectively. 11/22 (50.0%) DFUs and 13/28 (46.4%) VLUs achieved at least 40% closure at week 4. Average time to heal for all wounds was 10.6 weeks (range: 5 to 24 weeks). All wounds were 100% re-epithelialized by week 20 except one DFU that was re-epithelialized at week 24. All patients responded well to treatment, with no reported adverse reactions or adverse side effects. Discussion: Overall, the use of CECM covered with MB/GV PU antibacterial foam in an overweight, advanced-age population was successful with an average time to closure of 10.6 weeks for wounds in this series. It is interesting to note that 24/25 wounds that did not achieve greater than 40% wound surface area reduction by week 4 progressed to complete closure by week 20, with no additional wound treatment besides weekly application of CECM and MB/GV PU antibacterial foam dressings. Rates of wound size reduction at 4, 8, and 12 weeks were similar between VLUs and DFUs. Average % Wound Closure Patient outcomes n (%) Avg area Avg time Avg % area Avg % area Avg % area 40% 40% 100% 100% at 0 weeks to healing closed at closed at closed at closure at closure at closure at closure at (cm2) (weeks) 4 weeks 8 weeks 12 weeks 4 weeks n(%) 8 weeks n(%) 12 weeks n(%) 20 weeks n(%) Wounds treated (n) 53 (100.0) % 73.3% 91.3% 25 (47.2) 49 (92.5) 31 (58.5) 52 (98.1) DFU (n) 22 (41.5) % 76.5% 90.6% 11 (50.0) 20 (90.9) 13 (59.1) 21 (95.5) VLU (n) 28 (52.8) % 70.9% 92.6% 13 (46.4) 26 (92.9) 17 (60.7) 28 (100.0) PrU (n) 3 (5.7) % 72.0% 84.3% 1 (33.3) 3 (100.0) 1 (33.3) 3 (100.0) Wound surface area reduction over 20 weeks (percent) DFU (n=22) 60 VLU (n=28) 50 PrU (n=3) Weeks Compared to VLUs, DFUs showed a slightly greater percent size reduction rate at 8 weeks, but a lesser size reduction at 12 weeks. This is consistent with our observation that DFUs in this series took longer than VLUs to progress to full healing during the reepithelialization phase, but considerably more research is required to validate this observation. Drawing conclusions regarding pressure ulcer healing in this series was difficult due to low subject numbers. REFERENCES 1. Schultz GS, Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 2009;17(2): McCarty SM, Percival SL. Proteases and Delayed Wound Healing. Adv Wound Care (New Rochelle) Oct;2(8): Bohn G, Liden B, Schultz G, Yang Q, Gibson D. Ovine-based collagen matrix dressing: Next generation collagen dressing for wound care. Adv Wound Care (New Rochelle) 2016 Jan 1;5(1): Liden BA, May BC. Clinical outcomes following the use of ovine forestomach matrix (endoform dermal template) to treat chronic wounds. Adv Skin Wound Care Apr;26(4): Bohn GA, Gass K. Leg ulcer treatment outcomes with new ovine collagen extracellular matrix dressing: a retrospective case series. Adv Skin Wound Care Oct;27(10): * Endoform dermal template, Distributed by Hollister Incorporated. ** Hydrofera Blue Ready foam, Distributed by Hollister Incorporated. Financial disclosure: Author received an investigator-initiated research study grant from Hollister Incorporated Case Study Patient: 66 year-old male patient with history of T2DM and HIV presented with anterior left ankle wound secondary to increased compression from treatment of pressure ulcer to heel that was almost closed. Patient was self-treating wound when he changed his dressing and over-tightened the gauze wrap on his left ankle. Week 0: 4.5 cm x 4.5 cm x 0.4 cm Initial presentation Anterior tibialis tendon exposed Wound treatment: Sharp debridement, CECM dressing applied with MB/GV PU antibacterial foam cover with dressings applied twice a week. Week 13: 1.2 cm x 1.2 cm x0.1 cm 93% wound closure Wound treatment: CECM dressing applied with MB/GV PU antibacterial foam cover with dressings applied one time a week. Week 7 Complete granulation over the tendon with contraction of wound edges Wound treatment: CECM dressing applied with MB/GV PU antibacterial foam cover with dressings applied one time a week. Week 15 Complete epithelialization Lullove, E. (2016). Use of Ovine Collagen Extracellular Matrix and Gentian Violet and Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds. Symposium on Advanced Wound Care - Fall, Las Vega, NA. Caution: Federal (USA) law restricts this device for sale by or on the order of a physician or licensed healthcare professional. Refer to Instruction for Use for contraindications, warnings, precautions and possible complications. Endoform is a trademark of Aroa Biosurgery Limited Aroa Biosurgery Limited Manufactured for: AROA BIOSURGERY INC 340 Progress Drive, Manchester, CT
4 CASE STUDY 1 Mixed Vascular Disease Sex: Co-morbidities: Wound Type: Wound Location: Wound Age: Previous Treatments: Secondary Dressing: Outcomes: Endoform applications: Female Non-insulin dependent diabetes Congestive heart failure Congestive obstructive pulmonary disease Peripheral vascular disease Mixed Vascular Left ankle 1 year Compression Sharp debridement Silver dressing Steroid therapy Non-adherent dressing Rolled gauze Compression therapy Offloading pressure device Granulation tissue at Week 5 Complete healing at Week 11 9 Week 0: Week 7: Wound area over time Week 7:
5 Initial Preparation The wound was surgically debrided down to viable tissue and irrigated with hypochlorous acid solution and treated with a silver dressing and compression. The wound was assessed for visible signs of infection (i.e., absence of swelling, pain, purulent drainage, or tracking into the deep tissue planes). The wound had to remain free of infection to start using the Endoform dermal template. Silver dressing treatments were stopped at this time. Endoform dermal template Application Using aseptic technique, Endoform dermal template was trimmed to roughly overlap the wound margins, placed on the wound bed and rehydrated with sterile saline. Following hydration, the color of the dressing changed from white to opaque. Light pressure was applied to the dressing to ensure that it conformed to the underlying wound bed. The dressing was covered with a nonadherent secondary dressing. Compression stockings, exudate control and offloading were used as required. Follow-Up The patient received weekly follow-up, during which time the wound was debrided as required and irrigated to remove loose material. The Endoform dermal template was reapplied on a weekly basis. Changes in the wound granulation tissue, epithelial tissue and wound dimensions were monitored and recorded using digital photography. Observations In approximately three days, the dressing had adhered to the underlying wound bed. After seven days, the dressing was completely integrated into the wound bed. In some cases, only remnants of the dressing remained as an off-white gel that was allowed to remain in place during subsequent applications of Endoform dermal template. Case provided by: Liden BA, Ward BR, May BCH; Early Clinical Findings From The Use Of Endoform Dermal Template (Ovine Forestomach Matrix) To Treat Recalcitrant Wounds; Presented at Symposium on Advanced Wound Care, April 14-17, 2011 Dallas, TX. RX Only. Prior to use, be sure to read the entire Instructions for Use package insert supplied with the product. For product questions, sampling needs, or detailed clinical questions concerning our products in the US, please call HCPCS are for reference only and subject to change. Endoform is a registered trademark of Aroa Biosurgery Limited. Endoform Dermal Template is marketed in the USA by Appulse Manufactured for: AROA BIOSURGERY INC 340 Progress Drive, Manchester, CT Aroa Biosurgery Limited
6 CASE STUDY 3 Mixed Vascular Etiology Sex: Female Co-morbidities: Wound Type: Wound Location: Diabetes Congestive heart failure Venous reflux Mixed vascular Left lower medial leg, anterior ankle Week 0: Wound Age: 1+ year Previous Treatments: Secondary Dressing: Outcomes: Endoform applications: Compression Sharp debridement Enzymatic debrider Growth factos Skin substitute (x4) Silver dressing Non-adherent dressing Rolled gauze Granulation tissue at week 4 Complete Healing at week 9 6 Week 4: Wound area over time Week 9:
7 Initial Preparation The wound was surgically debrided down to viable tissue and irrigated with hypochlorous acid solution and treated with enzymatic debriding agent and compression. The wound was assessed for visible signs of infection (i.e., absence of swelling, pain, purulent drainage, or tracking into the deep tissue planes). The wound had to remain free of infection to start using the Endoform dermal template. Previously used dressings and enzymatic debriding treatments were stopped at this time. Endoform dermal template Application Using aseptic technique, the Endoform dermal template was trimmed to roughly overlap the wound margins, placed on the wound bed and rehydrated with sterile saline. Following hydration, the color of the dressing changed from white to opaque. Light pressure was applied to the dressing to ensure that it conformed to the underlying wound bed. The dressing was covered with a nonadherent secondary dressing. Compression stockings, exudate control and offloading were used as required. Follow-Up The patient received weekly follow-up, during which time the wound was debrided as required and irrigated to remove loose material. The Endoform dermal template was reapplied on a weekly basis. Changes in the wound granulation tissue, epithelial tissue and wound dimensions were monitored and recorded using digital photography. The wound was monitored for a further four weeks. Observations In approximately three days, the dressing had adhered to the underlying wound bed. After seven days, the dressing was completely integrated into the wound bed. In some cases, only remnants of the dressing remained as an off-white gel that was allowed to remain in place during subsequent applications of Endoform dermal template. Case provided by: Liden BA, Ward BR, May BCH; Early Clinical Findings From The Use Of Endoform Dermal Template (Ovine Forestomach Matrix) To Treat Recalcitrant Wounds; Presented at Symposium on Advanced Wound Care, April 14-17, 2011 Dallas, TX. RX Only. Prior to use, be sure to read the entire Instructions for Use package insert supplied with the product. For product questions, sampling needs, or detailed clinical questions concerning our products in the US, please call HCPCS are for reference only and subject to change. Endoform is a registered trademark of Aroa Biosurgery Limited. Endoform Dermal Template is marketed in the USA by Appulse Manufactured for: AROA BIOSURGERY INC 340 Progress Drive, Manchester, CT Aroa Biosurgery Limited
8 CASE STUDY 9 Venous Ulcer Patient: 53-year-old male, presented with a venous ulcer wound to the left ankle Wound characteristics and prior treatment: The wound was treated initially with zinc-paste-impregnated gauze and an alginate dressing Treatment: After debridement, wound measures 1 cm x 1 cm x 0.2 cm. Endoform dermal template treatment begun Week 3, wound measures 0.7 cm 0.8 cm x 0.1 cm Wound cleansed with normal saline Sharp debridement to remove devitalized wound base tissue Endoform dermal template was applied, covered with a secondary foam dressing, and secured with tape Week 4, wound measures 0.6 cm 0.9 cm x 0.2 cm Results: Initial wound measurement after debridement was 1.0cm x 1.0cm x 0.2cm After seven weeks of treatment, wound had decreased to 0.2cm x 0.2cm x 0.1cm Week 5, wound measures 0.4 cm 0.8 cm x 0.2 cm Week 7, wound measures 0.2 cm 0.2 cm x 0.1 cm
9 CASE STUDY 9 Venous Ulcer Case provided by: Maeve Curran, PT, CWS, CLT; Desert Regional Medical Center, Palm Springs, CA RX Only. Prior to use, be sure to read the entire Instructions for Use package insert supplied with the product. For product questions, sampling needs, or detailed clinical questions concerning our products in the US, please call HCPCS are for reference only and subject to change. Endoform is a registered trademark of Aroa Biosurgery Limited. Manufactured for: AROA BIOSURGERY INC 340 Progress Drive, Manchester, CT Endoform Dermal Template is marketed in the USA by Appulse 2018 Aroa Biosurgery Limited
10
11 Pub,, USh-.llbl'l'ol....,. PubMed H...,... H,, If> Advanced Help Foonat: Abstract Nav;29(11) $37--$42 Proactive and Early Aggressive Wound Management: A Shift in Strategy Developed by a Consensus Panel Examining the Current Science, Prevention, and Management of Acute and Chronic Wounds. illlllll.qmjgl!ulll,.zill1ama.=.liilllm,. Send to... Abstract Normal wound healing is aocotnplished th1ough a series of well-eoordinat&d, ptogressive events wi1h overlapping phases. Chronic wounds are desaibed as not progress i ng lo healing or nol being responsive lo mal\agement in a timely manner. A consensus panel 01 multidisciplinary wound care professionals was assembled to (1) educate wound ca.re practitioners by identifying key principles of the basic science of chroni<: wound pathophy-$iology, highlighting the impact of metalloproleklases and biofitms, as well 8$ the role of the e racellular matrix; and (2) equip practitioners with a syslematic strategy for lhe prevention and heating ol acule injuries and chronic wounds based upon scientific evidence and the panel members' expertise. An algorithm is presen1ed that represents a shifl in strategy to proactive and earty agg,essive wound management Wit11 proactive mamgement. adjuncl therapies a,e applied preemptively to acute injuries to reduce wound duration and risk ol ctironicity. For existi chronic wounds. earty aggressive wound management is employetd to bleak the pattioptiysiology cycle and drive wounds Ioward healing. Reducing biol>urden through debridernent and bioburden managemenl and using collagen dressings to balance protease act i vity prior to lhe use of advanced modalities may enhance their effectivefless. This earty aggressive wound management slrategy is reoommend&d for patients at high risk lor chronic: wound development al a minimum. In their own practices. lhe panel members apply lhis systemalic stralegy for aji patients presenting with acute injuries or Chronic wounds. PMID Free full text Full text links I,..,,_ti:: I.WOUNDS Save items Add to Favorites Similar 8rticles Community-based care lor chronic wound management: [Ont Health Temnol Assess ser. Management ot chronic pressure s: an evidencebas< [Ont Health Temnol Assess Ser. EWMA Documenl: Nogative Pressure Woond Therapy. IJ -.nc1 ca,e cmmm Systematic revie'ns ol womd caie management: (3),!Health Tect,nol Assess. 2000) C!ll'ElJ Recommenclalions f"' the management of biofilm: a consensu$ do< IJ _,ncl care 2016) see,ev1ews... Seeal... WOUNDS la.a\\l '7 < I 11 I q JCll ;,r., \L HCI.IE SUBSCRIBE l'bue \1ULT1MECIA EDLIC)TlON U0UlU3!IIGN JP LCG M in Proaclive and Early Aggressive Wound Management A Shifl in Strategy Developed by a Consensus Panel Examining tho Current Science, Prevention, and Management of Acute and Chronic Wounds 1-W'IU OOMMI.JNl(.;,\110!{emote errperature Moortonng 1n mati. c i=oot U l cn C c-tcc-j"' ill 11'11. 01/1,?"l I Orwc; PROACTIVE AN a EARLY AGGRESSIVE WOUND MANAGEMENT: A Shift in Strategy Des eloped tiy a Consensus Panel E<ilmining the Current Science, P,e,ent,on and Management of Acute and Chronic Wound, Abstrut l11bodud.iur1. i:l.llqh; r ll Llu:Mi. (OF Ji.: i:41'::i ass:dated \\'itt ioa..at,a,d 1101:,d ::y. n'iol'talir,'. ;md resource utilization. Rerrcte f raftlu! rrvdiulnn :RT\11"1 :'I H <!\1,1rm, r. t'i::rm :md r<'!n'lrrrnr.ndr. 1 w1n1,1u11 11l L f -li.111u,11j p1::vt11lt.1liv.: L ul c,ara torhi3h-<i : p Llations :hat car dgt;;ct lhe i111f amr a;:ion poeceding and IIN'.:-,... r;;n lfl!] 11FIJ r.:-.'lini1p r!'.=o,1inf1 MOST rorular ARTl::. s tlnrfor i;ndln!j Ol!'ll'W'!tk.lndur.Tlon nf Cdl JliJ1 Si.:m.: i.:cm;i:; A Cund:.c R.:vi w -OJUay:Q'V/101-li? Chairaderiitic!o ot U19ical Site l11 ction rcllo 1oin!=j Cclon-ctal Surge,r/ in o TErtief'l c.,mrp.r! F:rriP.:rwiP.il 'lflf:r:rrum fu nr.10mr. P.- 1J1Uth.n:i11f 8ai.;Lc1i;:, Cul iitit:. in Dbt. c::;t , '.&nflnl "'"""""' Edito,iol Meg e: Yoo U'fom to Spit on r.tywr,un:t'? -- -:sa,,1 2111s1r1 ni,lid!; tdiluti;:11 MY6ti,i,t\J ; Huv, Ou Yoo t1;-.11rji Adl"&ft.ity'i'
CLINICAL EVIDENCE Partial and Deep Partial Burns
CLINICAL EVIDENCE Partial and Deep Partial Burns Endoform helps to improve re-epithelialization after burn injuries Endoform helps to facilitate tissue granulation and epithelialization in partial and
More informationEric J. Lullove, DPM, CWS, FACCWS. Wounds 2017;29(4):
CASE SERIES Use of Ovine-based Collagen Extracellular Matrix and Gentian Violet/Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds: A Retrospective
More informationCLINICAL EVIDENCE Negative Pressure Wound Therapy (NPWT)
CLINICAL EVIDENCE Negative Pressure Wound Therapy (NPWT) Endoform forms part of the NPWT strategy Endoform fits seamlessly with NPWT approaches. Utilize Endoform within the wound bed to help stabilize,
More informationCLINICAL EVIDENCE Treatment of Diabetic Foot Ulcers (DFUs)
CLINICAL EVIDENCE Treatment of Diabetic Foot Ulcers (DFUs) Endoform helps reduce the time, cost and complication of closing diabetic foot ulcers Treating DFUs with Endoform following debridement can lead
More informationRegenerative Tissue Matrix in Treatment of Wounds
Regenerative Tissue Matrix in Treatment of Wounds Learning Objectives Differentiate between reparative and regenerative healing Review surgical techniques for applying a regenerative tissue scaffold to
More informationLower Extremity Wound Evaluation and Treatment
Lower Extremity Wound Evaluation and Treatment Boni-Jo Silbernagel, DPM Describe effective lower extremity wound evaluation and treatment. Discuss changes in theories of treatment in wound care and implications
More informationMean percent reduction in ulcer area from baseline at six weeks 62 % SANTYL Ointment + supportive care* + sharp debridement 1 (P<0.
Evaluating two common adjuncts to sharp debridement in the treatment of diabetic foot ulcers Mean percent reduction in ulcer area from baseline at six weeks 62 % 40 % SANTYL Ointment + supportive care*
More informationAdvancing the science of wound bed preparation
Advancing the science of wound bed preparation How Drawtex wound dressing works LevaFiber Technology provides three different types of action. Mechanisms of Action Capillary Action Hydroconductive Action
More informationWound Management. E. Foy White-Chu, MD, CWSP
Wound Management E. Foy White-Chu, MD, CWSP E. Foy White-Chu, MD, CWSP Assistant Professor, OHSU Wound Medical Director, VAPORHCS List the Four Principles of Wound Bed Preparation Determine safe debridement
More informationApplication Guide for Full-Thickness Wounds
Application Guide for Full-Thickness Wounds PriMatrix Dermal Repair Scaffold PriMatrix Ag Antimicrobial Dermal Repair Scaffold Application Guide for Full Thickness Wounds PriMatrix is a unique dermal repair
More informationThe Risk. Background / Bias. Integrating Wound Care into a Limb Preservation Initiative 4/24/2009
Stimulating Wound Granulation: Advances in NPWT and other Measures (Wound Bed Preparation) Charles Andersen MD, FACS, FAPWCA Clinical Prof of Surgery UW, USUHS Chief Vascular/Endovascular/ Limb Preservation
More informationo Venous edema o Stasis ulcers o Varicose veins (not including spider veins) o Lipodermatosclerosis
Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018 Effective for dates of service on or after July 1, 2018, wound care equipment and supply benefits will change for Texas
More informationThe Georgetown Team Approach to Diabetic Limb Salvage: 2013
The Georgetown Team Approach to Diabetic Limb Salvage: 2013 John S. Steinberg, DPM FACFAS Associate Professor, Department of Plastic Surgery Georgetown University School of Medicine Disclosures: None Need
More informationBIOBURDEN-BASED WOUND MANAGEMENT: A NEW PARADIGM. Ryan H. Fitzgerald, DPM, FACFAS
BIOBURDEN-BASED WOUND MANAGEMENT: A NEW PARADIGM Ryan H. Fitzgerald, DPM, FACFAS Contamination Presence of non-replicating microorganisms on the wound surface that evoke no clinical host response - All
More informationIntegra Flowable Wound Matrix
Integra Flowable Wound Matrix Table of Contents How Supplied...2 Storage...2 Product Information Disclosure...2 Symbols Used On Labeling...2 Instructions for Use... 3 Instructions for Use (Continued)...
More informationINTRODUCTION TO WOUND DRESSINGS
WOUND CARE INTRODUCTION TO WOUND DRESSINGS JEC 2017 Wound Care Successfully completed specialized skills training in Wound Management. WOUND CONDITIONS & SYMBOLS BY COLOURS Yellow Black Necrotic tissue
More informationDisclosures for Tarik Alam. Wound Bed Preparation. Wound Prognosis. Session Objectives. Debridement 4/26/2015
Disclosures for Tarik Alam Challenges in Managing Bioburden and Devitalized Tissue Tarik Alam RN, BScN, ET, MClSc(WH) Enterostomal Therapy Nurse tarikalam@hotmail.com Clinical Affairs Manager for Hollister
More informationTopical antimicrobials (antiseptics) Iodine, Silver, Honey
Topical antimicrobials (antiseptics) Iodine, Silver, Honey Iodine Honey Silver Enzymatic debridement Proteolytic enzyme, also called Proteinase Proteinase breaks the long chainlike molecules of proteins
More informationCASE 1: TYPE-II DIABETIC FOOT ULCER
CASE 1: TYPE-II DIABETIC FOOT ULCER DIABETIC FOOT ULCER 48 YEAR-OLD MALE Mr. C., was a 48-year old man with a history of Type-II diabetes over the past 6 years. The current foot ulcer with corresponding
More informationA Reprint from Surgical Technology International Volume 30
A Reprint from Surgical Technology International Volume 30 USE OF AN OVINE COLLAGEN DRESSING WITH INTACT EXTRACELLULAR MATRIX TO IMPROVE WOUND CLOSURE TIMES AND REDUCE EXPENDITURES IN A US MILITARY VETERAN
More informationWOUND CARE. By Laural Aiesi, RN, BSN Alina Kisiel RN, BSN Summit ElderCare
WOUND CARE By Laural Aiesi, RN, BSN Alina Kisiel RN, BSN Summit ElderCare PRESSURE ULCER DIABETIC FOOT ULCER VENOUS ULCER ARTERIAL WOUND NEW OR WORSENING INCONTINENCE CHANGE IN MENTAL STATUS DECLINE IN
More informationConsider the possibility of pressure ulcer development
Douglas Fronzaglia II, DO, MS LECOM Institute for Successful Aging LECOM Institute for Advanced Wound Care and Hyperbaric Medicine Consider the possibility of pressure ulcer development 1 Identify ulcer
More informationUnderstanding and Managing
Understanding and Managing MM s in Wound Bed Brock Liden DM, ABM, FAWCA Learning Objectives Review the four sequential phases of normal wound healing and recognize the BENEFICIAL effects of CONTROLLED
More informationCategorisation of Wound Care and Associated Products
Categorisation of Wound Care and Associated Products Version 9 March 2018 Surgical Dressing Manufacturers Association 2018 TAPES AND TRADITIONAL DRESSINGS Wound Dressings Swabs Taping Traditional Wound
More informationNovoSorb BTM. A unique synthetic biodegradable wound scaffold. Regenerating tissue. Changing lives.
NovoSorb BTM A unique synthetic biodegradable wound scaffold Regenerating tissue. Changing lives. Overview NovoSorb BTM is a unique synthetic biodegradable wound scaffold that delivers good cosmetic and
More informationEmbrace the Call to Wound Prevention and Care
CONCLUSION Embrace the Call to Wound Prevention and Care A challenging career Be part of an interprofessional team Help patients, families, communities Commit to lifelong learning To cure occasionally,
More informationAppropriate Dressing Selection For Treating Wounds
Appropriate Dressing Selection For Treating Wounds Criteria to Consider for an IDEAL DRESSING Exudate Management Be able to provide for moist wound healing by absorbing exudate or adding moisture Secure
More informationDressings do not heal wounds properly selected dressings enhance the body s ability to heal the wound. Progression Towards Healing
Dressings in Wound Care: They Do Matter John S. Steinberg, DPM FACFAS Associate Professor, Department of Plastic Surgery Georgetown University School of Medicine Dressings do not heal wounds properly selected
More informationSurgical Wounds & Incisions
Surgical Wounds & Incisions A Comprehensive Review Assessment & Management Alex Khan APRN ACNS-BC MSN CWCN CFCN WCN-C Advanced Practice Nurse / Adult Clinical Nurse Specialist www.woundcarenurses.org 1
More informationYour guide to wound debridement and assessment. Michelle Greenwood. Lorraine Grothier. Lead Nurse, Tissue Viability, Walsall Healthcare NHS Trust
Your guide to wound debridement and assessment Michelle Greenwood Lead Nurse, Tissue Viability, Walsall Healthcare NHS Trust Lorraine Grothier Clinical Nurse Specialist, Tissue Viability, Central Essex
More informationSDMA Categorisation of Wound Care and Associated Products
Version 7 - February 2015 TAPES AND TRADITIONAL DRESSINGS Traditional Wound Dressings Wound Dressings Packs Swabs Swabs Swab Products Adhesive Tapes Taping Sheets Absorbent Wadding Absorbent Dressings
More informationA New Approach To Diabetic Foot Ulcers Using Keratin Gel Technology
A New Approach To Diabetic Foot Ulcers Using Keratin Gel Technology Farheen Walid, BA, Shrunjay R. Patel, BSc, Stephanie Wu, DPM, MS Center for Lower Extremity Ambulatory Research (CLEAR), Scholl College
More informationClinical Policy: EpiFix Wound Treatment
Clinical Policy: Reference Number: PA.CP.MP.140 Effective Date: 03/18 Last Review Date: 04/18 Coding Implications Revision Log Description EpiFix (MiMedx Group) is dehydrated human amniotic tissue that
More informationTIME CONCEPT AND LOCAL WOUND MANAGEMENT
TIME CONCEPT AND LOCAL WOUND MANAGEMENT B. BRAUN WOUND CARE INTRODUCTION: TIME is a global care framework used to implement appropriate care plans and promote wound healing Tissue Management Inflammation
More informationTotal Contact Cast System
Total Contact Cast System Instructions for Use Products Included in Cutimed Off-Loader Select kit Qty Cutimed Cavity Sterile 1 ea. Cutisorb Cotton Gauze 2" x 2" 4 ea. Delta-Lite Conformable Fiberglass
More informationProntosan. Clean. Easy Wound Healing. Wound Cleansing
Prontosan Clean. Easy Wound Healing. Wound Cleansing CoE Infection Control Prontosan the unique combination of Betaine & Polihexanide reduces healing time removes and prevents biofilm prevents infections
More informationDisclosures. Outpatient NPWT Options Free up Hospital Beds, but Do They Work? Objectives. Clinically Effective: Does it Work?
4/16/16 Disclosures Consultant, Volcano Corporation Outpatient Options Free up Hospital Beds, but Do They Work? UCSF Vascular Symposium 16 Jonathan Labovitz, DPM Medical Director, Foot & Ankle Center Associate
More informationClinical. Summaries. 3M Tegaderm Matrix Matrix Dressing. Delayed wound healing: A major clinical problem
3M Tegaderm Matrix Matrix Dressing Clinical Summaries Delayed wound healing: A major clinical problem Chronic wounds have been defined as those that fail to progress through a normal, orderly, and timely
More informationSmart Solutions for Serious Wounds. An advanced bilayer dermal regeneration matrix FDA approved for the treatment of diabetic foot ulcers.
Smart Solutions for Serious Wounds An advanced bilayer dermal regeneration matrix FDA approved for the treatment of diabetic foot ulcers. A New Approach to Diabetic Foot Ulcer Care Supported by Over Two
More informationPatient Care Information
Patient Care Information A Guide to Healing Diabetic Foot Ulcers Questions? Contact us: Clinician: Phone #: In case of emergency, dial 9-1-1 Dermal Regeneration Matrix Overview Diabetic foot ulcers are
More informationAppropriate use of silver dressings
Appropriate use of silver dressings David Keast, Center Director, Aging Rehabilitation and Geriatric Care Research Centre, St Joseph s Parkwood Hospital, London, Ontario, Canada Role of antimicrobial dressings
More informationIntegra. PriMatrix Dermal Repair Scaffold PATIENT INFORMATION. Questions? Contact us: Clinician: Phone #: In case of emergency, dial 9-1-1
Integra PriMatrix Dermal Repair Scaffold PATIENT INFORMATION Questions? Contact us: Clinician: Phone #: In case of emergency, dial 9-1-1 Your Path to Recovery Your health care provider has chosen to use
More informationChronic wounds need an ideal microenvironment. NEXODYN TM can support the physiological healing process.
Chronic wounds need an ideal microenvironment. can support the physiological healing process. Wound microenvironment of chronic wounds represents a major therapeutic challenge¹ The most relevant factors
More informationA Reprint from Surgical Technology International XXVI
A Reprint from Surgical Technology International XXVI GENTIAN VIOLET AND METHYLENE BLUE POLYVINYL ALCOHOL FOAM ANTIBACTERIAL DRESSING AS A VIABLE FORM OF AUTOLYTIC DEBRIDEMENT IN THE WOUND BED ANDREW JOSEPH
More information1/5. Introduction. Primary endpoint Time to reach readiness for closure by surgical intervention or left for closure by secondary intention
1/5 Introduction Materials and methods Animal studies show that intermittent NPWT has potential to increase the rate of granulation tissue formation compared with adjustable intermittent (AI) NPWT 1 However,
More informationPOLYHEAL MICRO - INSTRUCTIONS FOR USE
POLYHEAL MICRO - INSTRUCTIONS FOR USE PRODUCT DESCRIPTION PolyHeal Micro is a medical device indicated for the treatment of wounds. It is comprised of a suspension of polystyrene negatively charged microspheres
More informationQUICK GUIDE SNAP THERAPY SYSTEM
QUICK GUIDE SNAP THERAPY SYSTEM Clinical Pathway to SNAP System Full holistic assessment of patient and wound Is the wound type indicated for NPWT use without contraindications 1? SNAP System is indicated
More informationHydroTherapy: A simple approach to Wound Management
Copyright Paul Hartmann Pty Ltd material may not be reproduced or used without written permission HydroTherapy: A simple approach to Wound Management HARTMANN Education Agenda Agenda Acute vs Chronic wounds:
More information4-layer compression bandaging system (includes microbe binding wound contact layer) Latex-free, 4-layer compression bandaging system
JOBST Comprifore JOBST Comprifore at a glance: provides effective levels of sustained graduated compression provides built in safety and ease of application Insures compliance and maximum healing for cost
More informationThe Power of a Hydroconductive Wound Dressing with LevaFiber Technology
The Power of a Hydroconductive Wound Dressing with LevaFiber Technology The first step in healing a chronic wound is to detoxify it by removing slough, necrotic tissue, exudate and bacteria, while keeping
More informationWHY WOUNDS FAIL TO HEAL SIMPLIFIED
WHY WOUNDS FAIL TO HEAL SIMPLIFIED 10 Some of the common signs of failure to heal with possible causes and some interventions WHY WOUNDS FAIL TO HEAL There must be adequate supplies of nutrients and oxygen
More informationWOUND CARE UPDATE. -Commonly Used Skin Substitute Products For Wound. -Total Contact Casting. Jack W. Hutter DPM, FACFAS, C. ped.
WOUND CARE UPDATE -Commonly Used Skin Substitute Products For Wound Closure -Total Contact Casting Jack W. Hutter DPM, FACFAS, C. ped. Commonly Used Skin Substitute Products for Wound Closure why are they
More informationThe Use of the. in Clinical Practice
The Use of the SNAP Therapy System in Clinical Practice It s an ultraportable, mechanically-powered disposable NPWT. By Animesh Bhatia, DPM, CWS This article is written exclusively for PM and appears courtesy
More informationNPUAP Mission. Clinical Practice Guidelines: Wound Dressings for the Management of Pressure Injuries. npuap.org
Clinical Practice Guidelines: Wound Dressings for the Management of Pressure Injuries Margaret Goldberg, MSN, RN, CWOCN June 29, 2016 NPUAP Mission The National Pressure Ulcer Advisory Panel (NPUAP) serves
More informationEnluxtra Self-Adaptive Wound Dressing
Enluxtra Self-Adaptive Wound Dressing Case Studies OSNovation Systems, Inc. www.anywound.com Enluxtra is the registered trademark of BASF, Inc. OSNovative Systems, Inc. 500 Laurelwood Rd, Ste 1 & 4, Santa
More informationUse of Non-Contact Low Frequency Ultrasound in Wound Care
Use of Non-Contact Low Frequency Ultrasound in Wound Care BLAIRE CHANDLER SEPTEMBER 29, 2015 VCU DPT CLASS OF 2016 Objectives Patient case overview Examine clinical evidence Review intervention of interest
More informationAcute and Chronic WOUND ASSESSMENT. Wound Assessment OBJECTIVES ITEMS TO CONSIDER
WOUND ASSESSMENT Acute and Chronic OBJECTIVES Discuss classification systems and testing methods for pressure ulcers, venous, arterial and diabetic wounds List at least five items to be assessed and documented
More information3M Tegaderm Matrix Matrix Dressing. Matrix. Your questions answered
3M Tegaderm Matrix Matrix Dressing Matrix Your questions answered 3M Tegaderm Matrix Matrix Dressing Frequently Asked Questions What is Tegaderm Matrix? Matrix is a wound dressing impregnated with polyhydrated
More informationMany patients with chronic wounds. Case reports. The use of Prontosan in combination with Askina Calgitrol : an independent case series
Case reports The use of Prontosan in combination with Askina Calgitrol : an independent case series Author: Liezl Naude Many patients with chronic wounds will develop infection (Landis et al, 2007; Sibbald
More informationBest practice wound management. Liz Milner Wound Consultant
Best practice wound management Liz Milner Wound Consultant The goals of wound care: reducing risks that inhibit wound healing, enhancing the healing process, and lowering the incidence of wound infections.
More informationDEBRIDEMENT. Professor Donald G. MacLellan Executive Director Health Education & Management Innovations
DEBRIDEMENT Professor Donald G. MacLellan Executive Director Health Education & Management Innovations DEBRIDEMENT Principles - CSD Methods of Debridement Biopsy options PRINCIPLES OF WOUND MANAGEMENT
More informationVenous Insufficiency Ulcers. Patient Assessment: Superficial varicosities. Evidence of healed ulcers. Dermatitis. Normal ABI.
Venous Insufficiency Ulcers Patient Assessment: Superficial varicosities Evidence of healed ulcers Dermatitis Normal ABI Edema Eczematous skin changes 1. Scaling 2. Pruritus 3. Erythema 4. Vesicles Lipodermatosclerosis
More informationNovel Approaches for Accelerating Wound Healing Negative Pressure Wound Therapy in Accelerating Wound Healing Telemedicine
Novel Approaches for Accelerating Wound Healing Negative Pressure Wound Therapy in Accelerating Wound Healing Telemedicine Dr. Julian Vitse, Montellier University Hospital, France Negative Pressure Wound
More information3M Tegaderm Matrix Matrix Dressing. Conquer Non-healing. Wounds
Conquer Non-healing Wounds Chronic wounds Chronic wounds have been defined as those that fail to progress through a normal, orderly and timely sequence of repair. Or, wounds that pass through the repair
More informationMaking the Most of your Dressing Products Catherine Hammond CNS/CNE
Making the Most of your Dressing Products 2013 Catherine Hammond CNS/CNE What do you need in your dressings cupboard? 2 Skin tear 3 4 Lack Confidence in Selecting Dressings? 5 Appropriate Use of Product
More informationRN Cathy Hammond. Specialist Wound Management Service at Nurse Maude Christchurch
RN Cathy Hammond Specialist Wound Management Service at Nurse Maude Christchurch 14:00-14:55 WS #141: Wound Infection - What You Need to Know 15:05-16:00 WS #153: Wound Infection - What You Need to Know
More informationDiscussion Topics. Calcium Alginates. DME For the Diabetic Foot 1/25/2017. Jeffrey D. Lehrman, DPM, FASPS, FACFAS, MAPWCA
DME For the Diabetic Foot Jeffrey D. Lehrman, DPM, FASPS, FACFAS, MAPWCA Editorial Advisory Board, WOUNDS Board of Directors, American Society of Podiatric Surgeons Board of Directors, American Professional
More informationWound Healing Community Outreach Service
Wound Healing Community Outreach Service Wound Management Education Plan January 2011 December 2011 Author: Michelle Gibb Nurse Practitioner Wound Management Wound Healing Community Outreach Service Institute
More informationWound Care per HHVNA Wound Product Formulary
Venous Ulcers ABI of 0.9-1.2 = normal blood flow An ABI MUST be obtained prior to inititiation of compression therapy. Compression is the Gold Standard of care to promote wound of venous ulcers. Elevation
More informationBeyond the Basics ImprovingYour Wound Care Knowledge. Berna Goldentyer RN, BSN, CWOCN Kathy Hugen RN, BSN, CWOCN
Beyond the Basics ImprovingYour Wound Care Knowledge Berna Goldentyer RN, BSN, CWOCN Kathy Hugen RN, BSN, CWOCN Projects and Posters These resources were developed by creative VA nurses who had no special
More informationTube Fasteners. Tube. Fasteners
Tube Fasteners Tube Fasteners Confidence is in the air. Provide an extra measure of protection with confidence. The AnchorFast Guard oral endotracheal tube fastener features an integrated tube protection
More informationULCERS 1/12/ million diabetics in the US (2012) Reamputation Rate 26.7% at 1 year 48.3% at 3 years 60.7% at 5 years
Jay Christensen D.P.M Advanced Foot and Ankle of Wisconsin 2-4% of the population at any given time will have ulcers 0.06-0.20% of the total population Average age of patients 70 years increased as more
More informationPalliative Care. EPUAP/NPUAP Publish New Pressure Ulcer Guidelines for. Treatment. Improving Quality of Care Based on CMS Guidelines 39
Treatment EPUAP/NPUAP Publish New Pressure Ulcer Guidelines for Palliative Care Dealing with the end of a loved one s life is difficult enough, but when wound and skin care issues are involved, the decisions
More informationNanogen Aktiv. Naz Wahab MD, FAAFP, FAPWCA Nexderma
Nanogen Aktiv Naz Wahab MD, FAAFP, FAPWCA Nexderma Patient BM 75 y.o female with a history of Type 2 Diabetes, HTN, Hypercholesterolemia, Renal insufficiency, Chronic back Pain, who had undergone a L3-L4
More informationNUMERATOR: Venous Leg Ulcers within the denominator that achieved healing or closure within 12 months of its initial encounter.
CDR 6: Venous Leg Ulcer outcome measure: Healing or Closure MEASURE STEWARD: Alliance of Wound Care Stakeholders and the US Wound Registry This measure was developed via a consensus process in collaboration
More informationV.A.C. Therapy Safety Information
Bringing Safety Home V.A.C. Therapy Safety Information Bleeding Precautions Dressing Change Frequency Foam Removal Important Information 2 Prior to use of V.A.C. Therapy System it is important for the
More informationEvaluating the use of a topical haemoglobin spray as adjunctive therapy in non-healing chronic wounds a pilot study Liezl Naude
Evaluating the use of a topical haemoglobin spray as adjunctive therapy in non-healing chronic wounds a pilot study Liezl Naude Abstract Wound Management Specialist Eloquent Health & Wellness Centre, Pretoria,
More informationWorkshop on Debridement
MEDICINSK TEKNIK I SÅRDIAGNOSTIK OCH SÅRBEHANDLING Monday, 20 th of april 2015 Stockholm Sweden Workshop on Debridement Sources for best practice Reference documents available in several languages : WHY
More informationBIOPAD CASE REPORT STUDIES
BIOPAD TM CASE REPORT STUDIES BIOPADTM CASE SERIES A N A LY S I S A N A LY S I S Wound Healing Rates Wound healing rates were tracked for 28 days in patients with Chronic non-healing wounds using BioPad
More information2008 American Medical Association and National Committee for Quality Assurance. All Rights Reserved. CPT Copyright 2007 American Medical Association
Chronic Wound Care ASPS #1: Use of wound surface culture technique in patients with chronic skin ulcers (overuse measure) This measure may be used as an Accountability measure Clinical Performance Measure
More informationGenadyne A4 and foam to treat a postoperative debridment flank abscess
Genadyne A4 and foam to treat a postoperative debridment flank abscess Michael S. DO, The Wound Healing Center Indianapolis, IN Cynthia Peebles RN D.O.N., Becky Beck RN Heartland at Prestwick NH Avon,
More informationVACUUM ASSISTED CLOSURE (V.A.C.) THERAPY: Mr. Ismazizi Zaharudin Jabatan pembedahan Am Hospital Kuala Lumpur
VACUUM ASSISTED CLOSURE (V.A.C.) THERAPY: Mr. Ismazizi Zaharudin Jabatan pembedahan Am Hospital Kuala Lumpur Learning Objectives Define Negative Pressure Wound Therapy (NPWT) Discuss guidelines for the
More informationHemostasis Inflammatory Phase Proliferative/rebuilding Phase Maturation Phase
The presenters are staff members of the CHI Health St. Elizabeth Burn and Wound Center. Many of the products discussed are used in our current practice but we have no conflict of interest to disclose.
More informationUnderstanding Debridement
Understanding Debridement Figure 1. Wound Healing Process Wound Blood Clot Blood Blood Vessel Fat Tissue The wound in the skin exposes deep tissue layers to the air. Scab Scab Exudate Granulation Tissue
More informationThis article is based on a symposium held
Advances in wound cleansing: an integrated approach LIZ OVENS Independent Tissue Viability Specialist Nurse SALLY IRVING Independent Tissue Viability Nurse Consultant This article is based on a symposium
More informationInstructions for Use. Wright Medical Technology 1023 Cherry Road Memphis, TN USA
Instructions for Use Wright Medical Technology 1023 Cherry Road Memphis, TN 38117 USA 1-800-238-7117 Processed from Donated Human Tissue for Wright Medical Technology by LifeCell Corporation One Millennium
More informationINTEGRATED THERAPEUTIC SOLUTIONS TO MANAGE AND PREVENT DIABETIC FOOT ULCERS
INTEGRATED THERAPEUTIC SOLUTIONS TO MANAGE AND PREVENT DIABETIC FOOT ULCERS UE REMOVE EXU D R IA ER T C D TISS UIL EB ATE AN DB A REMOVE REBUILD REDUCE Cutimed Siltec Sorbact featuring DACC Technology
More informationSKIN INTEGRITY & WOUND CARE
SKIN INTEGRITY & WOUND CARE Chapter 34 1 skin integrity: intact skin refers to the presence of normal skin layer uninterrupted by wound 2 WOUNDS DISRUPTION IN THE INTEGRITY OF BODY TISSUE CLASSIFIED AS:
More informationPressure Injuries: Prevention and Management. Sheila Moffatt RN BN IIWCC NSWOC
Pressure Injuries: Prevention and Management Sheila Moffatt RN BN IIWCC NSWOC Objectives for PI 1. Prevalence 2. Risk 3. Prevention 4. Recognize NPUAP 2016 PI categories/stages 5. Assessment and Treatment
More informationWound Classification. Overview
Overview Jeffrey A. Niezgoda, MD FACHM, MAPWCA, CHWS Review of Initial Wound Care Consultation Rational for Classification Wound Appearance Wound Etiology Management Algorithms Initial Wound Care Consult
More informationSAMPLE. HLTEN406A Undertake basic wound care. Learner resource. HLT07 Health Training Package. Version 2
HLT07 Health Training Package HLTEN406A Undertake basic wound care Learner resource Version 2 Training and Education Support Industry Skills Unit Meadowbank Acknowledgments The TAFE NSW Training and Education
More informationHow Wounds Heal: A Guide for the Wound-care Novice
C L I N I C A L P R A C T I C E How Wounds Heal: A Guide for the Wound-care Novice BY Christine Pearson Christine Pearson, RN, IIWCC, is a wound clinician for Vancouver Coastal Health and has worked in
More informationWound Care Evaluation by Kris Dalseg MS PT CWS CLT
Wound Care Evaluation by Kris Dalseg MS PT CWS CLT This document is intended to describe a standard wound care evaluation for healthcare practitioners. In healthcare, all aspects of our treatment have
More informationWound Dressing. Choosing the Right Dressing
Wound Dressing Choosing the Right Dressing Benefits of using the correct Drsg Helps create the optimal wound environment Increases healing rates Reduces pain Decreases infection rates Cost effective Care
More informationEffective Wound Healing: Getting Back to the Basics. Bill Richlen PT, WCC, DWC
Effective Wound Healing: Getting Back to the Basics Bill Richlen PT, WCC, DWC What Is Happening Currently? There is a lack of education in current wound care principles and evidence-based practice We have
More informationNegative Pressure Wound Therapy (NPWT)
Negative Pressure Wound Therapy (NPWT) Policy Number: Original Effective Date: MM.01.005 11/19/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 01/01/2015 Section: DME Place(s) of Service:
More informationWound Management for Nurses/Technicians What do we need to know?
Wound Management for Nurses/Technicians What do we need to know? Laura Owen European Specialist in Small Animal Surgery Lecturer in Small Animal Surgery, University of Cambridge The Acute Open Wound PPE
More information9 Day Certified Lymphedema & Wound Therapist (62.5 CE hrs On-line + 9 Days Live Training (8am 8pm *daily times vary; 153 CE hrs Total!
1 9 Day Certified Lymphedema & Wound Therapist (62.5 CE hrs On-line + 9 Days Live Training (8am 8pm *daily times vary; 153 CE hrs Total!) On-Line COURSE OUTLINE/Overview of Topics (62.5hrs): Lymphatics
More informationVenous. Arterial. Neuropathic (e.g. diabetic foot ulcer) Describe Wound Types & Stages of. Pressure Ulcers. Identify Phases of Healing & Wound Care
A dressing the situation at hand Describe Wound Types & Stages of Pressure Ulcers Identify Phases of Healing & Wound Care Goals Clarify Referral Protocol Lacerations- The goal is nearest to complete approximation
More information